These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34362059)
21. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440 [TBL] [Abstract][Full Text] [Related]
22. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy. Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843 [TBL] [Abstract][Full Text] [Related]
23. Management of an anticipated difficult airway in Hurler's syndrome. Gurumurthy T; Shailaja S; Kishan S; Stephen M J Anaesthesiol Clin Pharmacol; 2014 Oct; 30(4):558-61. PubMed ID: 25425785 [TBL] [Abstract][Full Text] [Related]
24. Growth impairment in mucopolysaccharidoses. Melbouci M; Mason RW; Suzuki Y; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2018 May; 124(1):1-10. PubMed ID: 29627275 [TBL] [Abstract][Full Text] [Related]
25. [Hearing loss and airway problems in children with mucopolysaccharidoses]. Santos S; López L; González L; Domínguez MJ Acta Otorrinolaringol Esp; 2011; 62(6):411-7. PubMed ID: 21757178 [TBL] [Abstract][Full Text] [Related]
26. Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know. Reichert R; Campos LG; Vairo F; de Souza CF; Pérez JA; Duarte JÁ; Leiria FA; Anés M; Vedolin LM Radiographics; 2016; 36(5):1448-62. PubMed ID: 27618324 [TBL] [Abstract][Full Text] [Related]
27. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease. Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565 [TBL] [Abstract][Full Text] [Related]
28. Epilepsy in mucopolysaccharidosis disorders. Scarpa M; Lourenço CM; Amartino H Mol Genet Metab; 2017 Dec; 122S():55-61. PubMed ID: 29170080 [TBL] [Abstract][Full Text] [Related]
29. Mandibular condyle morphology among patients with mucopolysaccharidosis: An observational study of panoramic radiographs. Schmid-Herrmann CU; Muschol NM; Fuhrmann VU; Koehn AF; Lezius S; Kahl-Nieke B; Koehne T Int J Paediatr Dent; 2022 Sep; 32(5):737-744. PubMed ID: 34967064 [TBL] [Abstract][Full Text] [Related]
30. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient. Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648 [TBL] [Abstract][Full Text] [Related]
31. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan. Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497 [TBL] [Abstract][Full Text] [Related]
32. The factors affecting lipid profile in adult patients with Mucopolysaccharidosis. Stepien KM; Stewart FJ; Hendriksz CJ Mol Genet Metab Rep; 2017 Sep; 12():35-40. PubMed ID: 28560179 [TBL] [Abstract][Full Text] [Related]
33. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses. Jones SA; Marsden D; Koutsoukos T; Sniadecki J; Tylee K; Phillippo S; Kakkis E Mol Genet Metab; 2020 Aug; 130(4):255-261. PubMed ID: 32563631 [TBL] [Abstract][Full Text] [Related]
34. Transnasal adenoidectomy in mucopolysaccharidosis. Harrison R; Schaefer S; Warner L; Mercer J; Jones S; Bruce I Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():149-152. PubMed ID: 29958599 [TBL] [Abstract][Full Text] [Related]
35. Advanced Techniques for Securing Airway in Mucopolysaccharidoses and the Impact of New Therapeutic Approaches. Mohammed YM; Khan S Cureus; 2020 Sep; 12(9):e10582. PubMed ID: 33110718 [TBL] [Abstract][Full Text] [Related]
36. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII. Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054 [TBL] [Abstract][Full Text] [Related]
37. Sleep abnormalities in untreated patients with mucopolysaccharidosis type VI. John A; Fagondes S; Schwartz I; Azevedo AC; Barrios P; Dalcin P; Menna-Barreto S; Giugliani R Am J Med Genet A; 2011 Jul; 155A(7):1546-51. PubMed ID: 21638759 [TBL] [Abstract][Full Text] [Related]
38. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II. Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810 [TBL] [Abstract][Full Text] [Related]
39. Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS). Stepien KM; Gevorkyan AK; Hendriksz CJ; Lobzhanidze TV; Pérez-López J; Tol G; Del Toro Riera M; Vashakmadze ND; Lampe C Orphanet J Rare Dis; 2020 May; 15(1):114. PubMed ID: 32410642 [TBL] [Abstract][Full Text] [Related]
40. Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis. Rutten M; Ciet P; van den Biggelaar R; Oussoren E; Langendonk JG; van der Ploeg AT; Langeveld M Orphanet J Rare Dis; 2016 Apr; 11():50. PubMed ID: 27112191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]